We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Industry Insights

How CRISPR Is Transforming High-Throughput Screening content piece image
Industry Insight

How CRISPR Is Transforming High-Throughput Screening

This article walks through the fundamentals of CRISPR screening and its most exciting applications, including unpicking cellular signaling networks, discovering how viruses like COVID-19 infect our cells and finding new drug targets.
One-Chip-Fits-All: Biofabrication of Hydrogel Fiber Architectures Using Flow Focusing Microfluidics content piece image
Industry Insight

One-Chip-Fits-All: Biofabrication of Hydrogel Fiber Architectures Using Flow Focusing Microfluidics

This article discusses an innovative biofabrication method that uses a single 3D hydrodynamic flow focusing chip to generate different hydrogel configurations with specific geometries for various biological applications.
Three Noteworthy Applications of CRISPR content piece image
Industry Insight

Three Noteworthy Applications of CRISPR

Only 10 years ago, Nobel prize-winning work introduced CRISPR as a new and powerful genome editing tool. Here, three noteworthy applications of the technology are highlighted.
“Rewriting the Textbook” for Precision Medicine content piece image
Industry Insight

“Rewriting the Textbook” for Precision Medicine

Technology Networks recently had the pleasure of speaking with Mark Fidock, vice president for Diagnostic Development, Precision Medicine at AstraZeneca, to find out how the company is “rising to the challenge” of delivering precision medicines for chronic diseases.
BYOD: The Future of Clinical Trials content piece image
Industry Insight

BYOD: The Future of Clinical Trials

BYOD has become an essential cornerstone of modern clinical trials. This article discusses the adoption of BYOD and the benefits it can bring to patients.
The Battle for Psychedelic Patents  content piece image
Industry Insight

The Battle for Psychedelic Patents

In this article, Technology Networks speaks with Mindset Pharma CEO James Lanthier about how patents work in the fast-changing psychedelics industry, what makes a patent effective and how newer compounds stack up against natural psychedelics.





Psilocybin Study To Investigate the Serotonin System in Autism content piece image
Industry Insight

Psilocybin Study To Investigate the Serotonin System in Autism

In this interview, we speak to research scientist Tobias Whelan, who is conducting a first-ever mechanistic study of psilocybin in autistic adults to understand how the serotonin system may differ in autistic and non-autistic individuals.
Preserving the Power of Clinical Data content piece image
Industry Insight

Preserving the Power of Clinical Data

Chris Sigley highlights some of the main findings from the Ethical Medicines Industry Group and Arkivum’s annual survey tracking the progress of digital transformation and clinical data strategies of 305 global life sciences organizations.
Broadening the Adoption of Pharmacogenomic Testing  content piece image
Industry Insight

Broadening the Adoption of Pharmacogenomic Testing

Technology Networks recently had the pleasure of speaking to Dr. Philip Empey, to learn more about the Pharmacogenomics Center for Excellence and how it is working to prove the clinical utility of predictive PGx testing.
A New Approach to T-Cell Therapy content piece image
Industry Insight

A New Approach to T-Cell Therapy

In this interview with Bryan Kobel, CEO of TC Biopharm, we find out about gamma-delta T-cell therapy, including how it works, its applications and how TC Biopharm developed its pioneering gamma-delta treatment for acute myeloid leukemia.
Advertisement